Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2022
2020
2019
Profitability Metrics
Gross Margin
86.97%
Operating Margin
50.43%
Net Margin
-0.61%
Efficiency Metrics
Revenue per Expense Ratio
2.02
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
52.56%
Income Tax Rate
-651,100,000.0%
EPS
-0.1400000000
Balance Sheet Analysis
Current Ratio
0.86
Cash Ratio
0.23
Working Capital
$-308.12M
Debt to Equity
77.54
Debt to Assets
73.52%
Equity Ratio
0.95%
Cash Flow Analysis
Operating Cash Flow Ratio
7.63%
Free Cash Flow Ratio
6.41%
CapEx to Revenue
1.22%
Dividends Paid
$638.07M
Stock Buybacks
No buybacks
Total Shareholder Returns
$638.07M
Cash Position Change
-29.43%
Detailed Growth Metrics
Core Performance
Revenue
19.62%
Net Income
-131.72%
EPS
-131.11%
Operating Income
-11.98%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
-2.66%
Operating Cash Flow
-98.00%
Free Cash Flow
-98.32%
Balance Sheet Health
Assets
-12.71%
Debt
-7.49%
Book Value per Share
-22.62%
Inventory
100.00%
Shareholder Returns
Dividends per Share
-95.31%
Shares Outstanding
0.83%
Long Term Trends
3Y Revenue/Share
-5.32%
5Y Revenue/Share
0.00%
3Y Dividend/Share
-97.91%
5Y Dividend/Share
0.00%